Pancreatic Surgery Clinical Trial
Official title:
Outcome After Pancreatectomy for Neuroendocrine Tumor and Evaluation of the WHO 2017 Grading System: a Retrospective Multicentric Analysis of 138 Consecutive Patients.
Aim: The aim of this study was to investigate the clinicopathological factors and to evaluate
the prognostic accuracy of the new World Health Organization (WHO) 2017 grading system in
pancreatic neuroendocrine tumor (PanNET) patients.
Methods: Data collected between 1997 and December 2017 were analyzed. Histological grading
and staging was based on the WHO 2017 grading system. Outcome after surgery and predictors of
overall survival (OS) and disease free survival (DFS) were evaluated.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03000946 -
Prevention of Postoperative Pancreatic Fistula by Somatostatin
|
Phase 3 | |
| Not yet recruiting |
NCT03462602 -
Nasogastric Tube in Pancreatic Surgery
|
N/A | |
| Recruiting |
NCT05603702 -
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
|
Phase 1 | |
| Completed |
NCT04196816 -
Surgery for Pancreatic Cancer With Oligo-Metastasis
|
||
| Completed |
NCT01059097 -
Effect of Surgeon Volume on Outcome of Pancreaticoduodenectomy
|
N/A | |
| Withdrawn |
NCT00671463 -
Pancreatic Stent to Prevent Leak After Distal Pancreatectomy
|
N/A |